← Back to catalogue

Lumipulse G CA125II Immunoreaction Cartridges

FDA UDI

Class II (US FDA UDI)

by Fujirebio Inc.

Identity

Trade Name
Lumipulse G CA125II Immunoreaction Cartridges FDA UDI
Generic Name
Cancer antigen 125 (CA125) IVD, kit, chemiluminescent immunoassay FDA UDI
Model / Reference
234273 FDA UDI

Identifiers

Primary DI / UDI-DI
04987270234273 FDA UDI
510(k) Number
K142895 FDA UDI
FDA Product Code
LTK FDA UDI
GMDN Term
Cancer antigen 125 (CA125) IVD, kit, chemiluminescent immunoassay FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.6010 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Cancer antigen 125 (CA125) IVD, kit, chemiluminescent immunoassay

Lumipulse G CA125II Immunoreaction Cartridges by Fujirebio Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Cancer antigen 125 (CA125) IVD, kit, chemiluminescent immunoassay.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Fujirebio Inc.

Sources (1)

  • FDA UDI 06a68af9-742a-4687-95d8-302ad7cd990b 36 fields · synced Jun 8, 2026